Deals Shaping The Medical Industry, November 2014
You may also be interested in...
FDA Advisory Committees Continue To Come Under Congressional Scrutiny
Rep. Anna Eshoo, the ranking Democrat on the House Energy and Commerce health subcommittee suggested FDA and CDC vaccine advisory committees contributed to the public’s confusion during the pandemic response.
Chinese Companies Progress Peptide Fusion Inhibitors For COVID-19
China's Hybio, Youcare and Shanxi Jinbo appear to be the only three companies in the world trying to develop a fusion inhibitor for COVID-19, the most advanced of which has now moved into a domestic Phase II trial.
J&J’s Talc Subsidiary Not ‘Financially Distressed’ Enough For Bankruptcy – Third Circuit
The J&J company holding the firm’s liabilities relating to talc litigation, which declared bankruptcy in 2021 shortly after its formation, had its Chapter 11 petition denied by the Third Circuit on 30 January. Attorneys weigh in on the implications for J&J and wider industry.